ZEKE CAPITAL ADVISORS, LLC – Gilead Sciences, Inc. Transaction History
ZEKE CAPITAL ADVISORS, LLC portfolio value:
$397,000
portfolio value
ZEKE CAPITAL ADVISORS, LLC quarter portfolio value change:
-0.19%
quarter
Gilead Sciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.80% | 114 shares | 5K | $61.69 | 6.44K |
| Q2 2022 | share | Decrease | -2.01% | -130 shares | 7K | $61.81 | 6.33K |
| Q1 2022 | share | Increase | 0.00% | 6.46K shares | 385K | $59.45 | 6.46K |
| Q1 2020 | share | Decrease | -100.00% | -36.04K shares | -2.34M | $70.22 | 0 |
| Q4 2019 | share | Increase | +154.33% | 21.87K shares | 1.44M | $60.43 | 36.04K |
| Q3 2019 | share | Decrease | -38.88% | -9.01K shares | -668K | $58.4 | 14.17K |
| Q2 2019 | share | Increase | +3.46% | 775 shares | 109K | $61.67 | 23.18K |
| Q1 2019 | share | Increase | +14.71% | 2.87K shares | 235K | $58.79 | 22.41K |
| Q4 2018 | share | Increase | +8.53% | 1.53K shares | -168K | $56.02 | 19.53K |
| Q3 2018 | share | Increase | +30.61% | 4.21K shares | 414K | $68.57 | 18.00K |
| Q2 2018 | share | Decrease | -59.49% | -20.24K shares | -1.58M | $62.43 | 13.78K |
| Q1 2018 | share | Increase | +93.86% | 16.47K shares | 1.30M | $65.91 | 34.02K |
| Q4 2017 | share | Decrease | -26.79% | -6.42K shares | -685K | $62.19 | 17.55K |
| Q3 2017 | share | Increase | +159.38% | 14.73K shares | 1.28M | $69.84 | 23.97K |
| Q2 2017 | share | Decrease | -41.43% | -6.53K shares | -418K | $60.63 | 9.24K |
| Q1 2017 | share | Increase | +36.92% | 4.25K shares | 247K | $57.72 | 15.77K |
| Q4 2016 | share | Increase | +318.90% | 8.77K shares | 621K | $60.39 | 11.52K |
| Q3 2016 | share | Increase | 0.00% | 2.75K shares | 204K | $66.31 | 2.75K |